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OBJECTIVES: The pharmacological effects of methylprednisolone (MP) and ganglioside gM-1 on spinal injuries have been 
thoroughly investigated, but only a few studies have evaluated the interaction between these two drugs.
METHODS: Twenty-four Wistar rats were subjected to contusive injury of the spinal cord produced by the NYU system. These 
animals were divided into four groups: group I was injected with MP; group II was injected with gM-1; group III was injected 
with MP together with gM-1; and group control received physiological serum. The animals were evaluated with regard to their 
recovery of locomotive function by means of the BBB test on the second, seventh and fourteenth days after receiving the contusive 
injury to the spinal cord. They were sacrificed on the fourteenth day.
RESULTS: This study demonstrated that the MP and gM-1 groups presented functional results that were better than those of the 
control group, although the enhanced recovery of group II (gM-1) relative to the control group was not statistically significant 
(p>0.05). The most notable recovery of locomotive function was observed in the group that received MP alone (p<0.05). The group 
that received MP together with gM-1 presented results that were better than those of the control group (p<0.05).
CONCLUSION: Administration of methylprednisolone alone or with gM-1 was shown to be effective for recovery of locomotive 
function. Combined administration of these drugs resulted in better outcomes than administration of methylprednisolone alone.
KEYWORDS: Methylprednisolone. ganglioside gM-1. Spinal cord. Wistar rats. Motor activity.
INTRODUCTION
Spinal injuries occur at an annual rate of 15 to 40 cases 
per million people in developed countries. The main causes 
of spinal cord trauma are motor vehicle accidents, sports, 
recreational activities, work accidents, gunshot wounds and 
falls within the home.1 Approximately half of the patients 
who suffer spinal cord trauma present with complete rupture 
without any preservation of sensory or motor function below 
the level of the injury. This type of injury is devastating for 
a patient’s quality of life.2
Two distinct events occur during the course of spinal 
injuries. The first is an acute mechanical trauma that injures and 
compromises neural elements. The second is the development of 
secondary lesions caused by progressive ischemia and hypoxia, 
which trigger further biological events.2
Several drugs minimize secondary spinal lesions. These 
drugs are used to improve the potential for neurological 
recovery among spinal injury patients. The aim of this 
therapeutic strategy is to maintain the integrity of the neural 
elements that did not suffer anatomical injury due to the 
acute trauma.3
Methylprednisolone (MP) has been intensely investigated. 
Because of its pharmacological properties, it is considered to 
be neuroprotective.4 
Monosialoganglioside (gM-1) is a therapeutic alternative 
for treating lesions of the central nervous system (CNS). A 
variety of properties have been attributed to gM-1. gM-1 376
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has been shown to reduce neuronal edema by promoting 
activation of sodium, potassium and magnesium pumps. 
Furthermore, it has been shown to facilitate nerve cell 
homeostasis by re-establishing the membrane equilibrium.5 
In addition, it has been shown to increase the presence of 
endogenous neurotrophic factors. These activities diminish 
the destruction of neurons following trauma by increasing 
the plasticity of lesioned medullary circuits and hastening 
the recovery of the functional connections6.
Some authors have emphasized the importance of 
experimental studies that evaluate the results of combined 
administration of gM-1 and methylprednisolone for the 
treatment of spinal injuries7 since few published studies have 
this objective. Most of the published papers on this topic are 
based on clinical evidence and not on experimental studies.
The  principal  experimental  study  of  this  drug 
combination (MP + gM-1) was published in 1994. This 
study concluded that combined treatment with these two 
drugs did not provide any benefit to patients suffering from 
spinal injuries8. Importantly, this result has been questioned 
by other authors.3, 9
The New York University (NYU) system10 for producing 
spinal injuries by compression in small-sized animals has 
been implemented at our Institution. Many centers in various 
countries have been greatly encouraged to carry out studies 
on spinal injuries produced by the NYU system, following 
the international standards of the Multicenter Animal Spinal 
Cord Injury Study (MASCIS).
The Basso, Beattie and Bresnahan (BBB) locomotor 
scale11 was developed in 1995 to enable evaluation of 
locomotor recovery patterns among rats subjected to spinal 
injury using the NYU system. It is important to emphasize 
that this locomotor function evaluation system has not 
been applied within our environment until now. Moreover, 
we have not found any published reports of its use in the 
investigation of the effects of combined administration of 
methylprednisolone and gM-1.
The objective of this study was to evaluate the recovery 
of locomotor function in rats with spinal injuries, which 
were produced using the NYU system, following treatment 
with methylprednisolone, gM-1, and methylprednisolone in 
combination with gM-1, by means of the BBB scale.
MATERIALS AND METHODS
Twenty-four young male adult Wistar rats of mean 
weight 327 g (minimum of 302 g, maximum of 346 g and 
standard deviation of 13.5 g) were studied. The animals were 
kept in the microsurgery laboratory in climate-conditioned 
chambers at a temperature of 25 °C. They were housed in 
individual cages with light/dark cycles of 12 hours. Food 
was available ad libitum.
The rats in the experimental group were randomized, 
identified and divided into four groups of six rats each. All 
of the rats underwent laminectomy and spinal cord contusion 
using the NYU system by means of dropping a weight of 
10 g from a height of 25 mm. These groups received the 
following drugs: group I was injected with MP; group II was 
injected with gM-1; group III was injected with MP together 
with gM-1; and group IV (control) was injected with 0.9% 
physiological serum.
For the anesthesia procedure, pentobarbital was 
administered via the intraperitoneal route at a dose of 65 mg/
kg. A skin incision of approximately 5 cm was made along 
the dorsal medial line. The paravertebral musculature was 
separated from the spinous processes to expose the vertebral 
column from T8 to T12. Then, with an appropriate punch, 
laminectomy was performed in the distal half of T9 and T10, 
without causing injury to the dural sac, thereby allowing 
enough space to accommodate the impactor head (Figure 1).
The injury was produced using the NYU system, as 
developed by gruner,12 in 1992. (Figure 2).
After receiving the spinal injury, the animal was 
transferred to a temperature controlled chamber. The 
animal’s rectal temperature was measured 15 minutes 
after the injury and its bladder was emptied by manual 
compression at six hours and 24 hours post-injury and then 
daily until it was sacrificed.
Locomotor function was evaluated by the BBB scale, 
which was published in 1995, on the second, seventh and 
fourteenth days after the spinal contusion. Hip, knee and 
ankle joint movements were observed on the basis of this 
scale, along with the positions of the trunk, tail and hind 
paws. From these observations, the animal received a score 
between 0 and 21 such that 0 indicated total absence of 
Figure 1 - Exposure of the dura mater following laminectomy377
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movement and 21 indicated normal movement. Four doctors 
were trained as observers and formed the study group that 
evaluated the animals on the BBB scale.
The animals were sacrificed fourteen days after receiving 
the injury by intraperitoneal application of 140 mg/kg 
pentobarbital, in accordance with the rules and regulations 
of the ethics committee that analyzed the project.
The statistical analyses were both descriptive and 
comparative. For the quantitative variables (weight and 
scores on the second, seventh and fourteenth days after the 
injury), this analysis was done by observing the minimum 
and maximum values and calculating their means, standard 
deviations and medians. Absolute and percentage frequencies 
were also calculated.
Comparative analyses were performed using the Fisher 
exact test, Kruskal-Wallis nonparametric test, Friedman 
nonparametric test and Dunn multiple comparisons test. 
These tests were performed at a significance level of 5% (p 
= 0.05).
RESULTS
Table 1 shows the results of the functional evaluation, 
according to the BBB locomotor scale, for all groups on the 
second, seventh and fourteenth days after the spinal injury. 
The means of the values obtained at these three times are 
shown in Table 2.
Statistical analysis was performed on the comparative 
results from the BBB test at each time. From the Friedman 
nonparametric test, groups I, II, III and the control presented 
significant changes at the times evaluated (p<0.01). From 
comparisons in successive pairs, the results from the second 
day following the spinal injury were significantly different 
from the results on the fourteenth day for all of the groups 
(p<0.05). There was no statistical difference in comparisons 
Figure 2 - NYU system
Table 1 - Functional evaluations on the second, seventh and 
fourteenth days following the spinal injury
Rat 2nd day 7th day 14th day
group I
1 0 7 10
2 3 7 12
3 6 8 13
4 3 1 5
5 0 7 12
6 0 6 13
group II
1 1 1 8
2 0 1 1
3 0 1 8
4 2 7 12
5 0 8 7
6 0 1 8
group III
1 0 8 12
2 1 7 13
3 0 4 8
4 0 6 10
5 0 7 8
6 0 8 10
Control
1 1 2 2
2 0 1 4
3 0 3 3
4 1 1 3
5 0 4 4
6 0 2 2
Table 2 - BBB functional evaluations on the second, seventh 
and fourteenth days following the spinal injury 
groups 2nd day 7th day 14th day Mean for 
each group
group I 2.0 6.0 10.8 6.3
group II 0.5 3.2 7.3 3.7
group III 0.2 6.7 10.2 5.7
Control  0.3 2.2 3.0 1.8
Mean for each 
evaluation day
0.8 4.5 7.8
of the groups between the seventh day following the spinal 
injury and the other two times (Table 2 and Figure 3).
From the Kruskal-Wallis test, we observed that the 
groups were statistically different from each other at some 
of the evaluated times. In the evaluation of the seventh day 
following the spinal injury, the rats in group III presented 
significantly better locomotor function than did the control 
group (p<0.05). groups I and III presented a higher mean 
than that seen in the control group on the fourteenth day 
following the spinal injury (p<0.05) (Table 2).378
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DISCUSSION
Several experimental models have been developed to 
simulate spinal injuries using a weight that freely falls onto 
animals’ spinal cords.13 The paper published by Basso, et al,14 
however, has enabled a great advance in experimental studies 
on spinal injuries through use of the NYU system. 
Experimental evaluations of the efficacy of a drug in 
the treatment of an animal with a spinal injury require 
the production of a standardized injury with a locomotor 
function response that is as similar as possible between 
multiple animals.14-15
Our experiments involved rats, in accordance with the 
norms of MASCIS. When rats are subjected to spinal cord 
injuries, they present degrees of locomotor function recovery 
that may be reproducible.16
We chose to use the NYU system because it allows 
precise monitoring of the height from which the weight 
falls, the impact velocity and the compression rate for all the 
animals. This process ensured that we were able to produce 
calibrated and controlled spinal cord trauma, as demonstrated 
by Basso et al.14
The NYU system can be calibrated such that the fall 
originates from a rod at a height of 12.5, 25 or 50 mm. We 
chose the height of 25 mm because a fall from the height 
of 50 mm would cause a complete spinal lesion with high 
mortality within the first week, while rats with injuries from a 
weight falling from a height of 12.5 mm would present almost 
complete recovery within 10 days.10 Several researchers have 
developed tests to measure locomotor, sensory and reflex 
functions in animals following spinal contusions17. These 
authors have presented descriptive scales for locomotor 
performance that have not allowed for precise evaluation of 
the evolution of the animals’ locomotor recovery.11
The ideal tool for evaluating locomotor function should 
be easy to use, sensitive and capable of rapidly showing 
changes, even among a limited number of experimental 
animals.14 Today, the evaluation method that comes closest 
to this ideal is the BBB scale, which is a qualitative scale 
similar to the one originally described by Tarlov11.
This model of locomotive assessment (BBB) has been 
used by several authors18-20. As Basso et al11 concluded, other 
authors concur that the BBB tool is a valid and applicable 
method that can be used to predict and assess the steps 
of locomotive recuperation, differentiating the behavior 
outcomes at several time points.
The locomotion measurements proposed in the BBB 
evaluation scale were reproducible among the examiners 
trained in our study group. We emphasize that the BBB 
test must be performed by two trained examiners who have 
mastered the attributes of the scoring card and the terms on 
the evaluation scale with a minimum observation time of 
four minutes for each animal. The examiners must keep the 
key for this scale at hand, make systematic annotation of the 
results, re-evaluate the differences found between the results, 
and repeat the test if necessary. This procedure results in a 
reduced risk of interpretation error.
In our study, we sacrificed animals on the fourteenth 
day following the initial spinal injury since the objective 
was to analyze the effects of functional recovery during the 
acute phase. The study by Basso et al,11 which analyzed the 
evolution of locomotor function using the BBB method, 
demonstrated that the animals that underwent spinal 
contusion using the NYU system presented significant 
recovery from the fourteenth day after the initial trauma 
onwards without the use of drugs (score on the BBB scale 
greater than 10). This was confirmed by a subsequent study 
by Basso et al.14 These authors demonstrated that it was 
unusual for the animals to exceed a score of six on the 
BBB scale until two weeks after the injury occurred. We 
considered this to be an important factor in our study design 
since any significant improvement in locomotor function 
within this initial time period might be interpreted as a 
result of the action of MP with or without concomitant use 
of gM-1.
From our analysis of locomotor function, we observed a 
significant improvement in the functional deficit for all of the 
rats within the same group, as indicated by comparing scores 
obtained on the second and fourteenth days following the 
spinal injury. The statistical analysis of the BBB test scores 
between the second and seventh days showed significant 
paralysis of the animals’ hind limbs, with scores between 
a minimum of one and a maximum of eight, without any 
significant difference within the groups or between the 
groups. These findings suggest that there was an initial 
transitory stoppage of spine physiological function that was 
Figure 3 - Evolution of the mean values for functional evaluations, on the 
second, seventh and fourteenth days after causing the spinal injury, for groups 
g I, g II, g III and g IV379
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more severe than the definitive neurological deficit. This is in 
agreement with the postulations made by Basso et al.14
These observations indicate that a spinal contusion 
resulting from the NYU system, with a load of 10 g at a 
height of 25 mm, is capable of producing an incomplete 
spinal cord injury in rats. We confirm that locomotor 
evaluation by the BBB method after the first 48 hours 
did not reflect the definitive result from the neurological 
injury. This finding is concordant with the results reported 
by Constantini8 and Basso et al.11,14 Most spinal contusions 
caused in experimental animals are incomplete injuries of 
the spinal cord, in which at least a band of white substance 
is preserved.21 The potential for recovery depends upon the 
maximum possible viability of the ascending and descending 
axons remaining in the white substance and its myelinization. 
Pharmacological strategies generally focus on controlling the 
secondary lesion process in the spinal cord (primarily lipid 
peroxidation) and maintaining the viability of as many of the 
elements of the white substance as possible.3
Although various substances have been used to attenuate 
the effects of spinal injuries following acute trauma, we 
chose to utilize methylprednisolone in this study because 
it provides clinical benefits to subjects with spinal injuries, 
including improvements in neurological function, as 
demonstrated in several studies.9, 22
Yoon et al23 affirmed that the spinal injury model 
that employs the NYU system presents a very short 
therapeutic window and that the best results from the use 
of methylprednisolone are obtained with a dose of 30 mg/
kg applied within the first 30 minutes after the injury. On 
the basis of that study, we applied a dose of 30 mg/kg of 
methylprednisolone in bolus form to the rats (group I) 
five minutes after the spinal contusion. We repeated this 
dose three hours later, following the protocol proposed by 
Constantini and Young.8
From our analysis of the results on the BBB scale, 
we saw that there was a significant difference between 
group I and the control group, with improvement in the 
locomotor function of the group I animals. This finding 
suggests that methylprednisolone may attenuate the 
effects of the secondary lesion on the spinal cord, resulting 
in improvement of locomotor function at the cost of 
anti-inflammatory effects18,24-26. These findings conflict 
with those of Rabchevsky et al27 and Marcon,28 who did 
not observe functional improvements with the use of 
methylprednisolone.
We used gM-1 in group II because some clinical studies 
have documented beneficial effects following treatment with 
gM-1. For instance, gM-1 administration improved the 
neurological function of patients with spinal cord trauma in 
the acute and chronic phases.6 Other authors have described 
beneficial effects regarding neurological recovery, which 
they attributed to an increased axonal dopaminergic effect. 
This effect was associated with the removal of factors that 
would inhibit the regeneration of nerve fibers and with the 
capacity of gM-1 to reduce the retrograde degeneration of 
axons.29 Furthermore, Borzeix et al30 observed an increase 
in blood flow in the injured spinal cord following the 
application of gM-1.
We did not find any evidence of significant improvement 
in locomotor function in group II (gM-1) relative to the 
control group. There may be, however, beneficial effects 
of long-term treatment since most of the beneficial effects 
of gM–1 are not observed in the acute phase31. We draw 
attention to the fact that group II performed better than 
the control group, but without any statistically significant 
difference. Long-term studies may allow for a more accurate 
interpretation of the benefit of gM-1 in the treatment of 
spinal cord lesions.
We co-administered methylprednisolone and gM-1 in 
group III since some recent experimental studies have drawn 
attention to the possibility that specific drug cocktails might 
increase the known beneficial effects of methylprednisolone 
on spinal cord injuries. Moreover, these studies emphasized 
that methylprednisolone and gM-1 have been demonstrated 
to be beneficial in the treatment of patients with spinal cord 
injuries.32
In our analysis of the evolution of locomotor function 
recovery, we observed improvement in the functional deficit of 
group III, which suggests that the combined activity of these 
drugs promotes locomotor recovery among animals that have 
undergone spinal injury. These results were in disagreement 
with those found in an experimental study by Constantini and 
Young8. This earlier study concluded that gM–1 blocked the 
neuroprotective effects of methylprednisolone and that this 
combination of drugs was worse than their use separately. 
This conclusion was based upon measured ion volumes. 
Importantly, they did not evaluate the evolution of the 
functional recovery pattern among the animals after treatment. 
We must emphasize that we did not carry out ion volume 
measurements, so the difference in results between our study 
and that of Constantini and Young8 may result from our use of 
different methodologies.
Despite the fact that co-administration of methyl-
prednisolone with gM-1 during the acute phase of spinal cord 
injuries in rats resulted in beneficial functional outcomes, one 
cannot say that this drug regimen is recommended in humans. 
All of the studies that have assessed the effects of this drug 
regimen during the acute phase of injury are experimental 
studies. Our results indicate that subsequent clinical studies 
should initiate the use of gM-1 only after the third day 
following a spinal cord injury.6380
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CONCLUSIONS
1) Methylprednisolone was shown to effectively promote 
locomotor function recovery. From a comparison between 
the three treatment groups, the best functional results were 
obtained when this drug was used alone.
2) The functional recovery among the animals that 
received gM-1 was superior to that of the control group, 
although this difference was not statistically significant.
3) The functional recovery of the animals that received 
methylprednisolone together with gM-1 was superior to that 
of the control group.
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